{"SPADE_UN_25531": {"Sequence Information": {"Peptide Name": "KR-12 (6-12)+hBD-3 (36-45)[R1N]", "Sequence": "RIKDFLRNGRKCCRRKK", "Sequence Length": 17, "Biological Activity": ["Anti-Gram+", "Anti-Gram-"], "Binding Target": "", "Source": "", "Gene": "", "PDB ID": "", "UniProt Entry": [{"uniprotId": "P49913", "uniprotUrl": "http://www.uniprot.org/uniprot/P49913", "description": "The amino acid sequence of the current peptide coincides with the part of the UniProt entry that represents a peptide precursor."}, {"uniprotId": "P81534", "uniprotUrl": "http://www.uniprot.org/uniprot/P81534", "description": "The amino acid sequence of the current peptide coincides with the part of the UniProt entry that represents a peptide precursor."}], "Literature": [{"Title": "Hybrid derivative of cathelicidin and human beta defensin-2 against Gram-positive bacteria: A novel approach for the treatment of bacterial keratitis.", "Pubmed ID": "34526600", "Reference": "Sci Rep. 2021;11:18304", "Author": "Ting DSJ, Goh ETL, Mayandi V, Busoy JMF, Aung TT, Periayah MH, Nubile M, Mastropasqua L, Said DG, Htoon HM, Barathi VA, Beuerman RW, Lakshminarayanan R, Mohammed I, Dua HS", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/34526600"}], "Mass": 2177.65, "PI": 11.47, "Net Charge": 8, "Hydrophobicity": -1.73, "Frequent Amino Acids": "RKC", "Absent Amino Acids": "AEHMOPQSTUVWY", "Basic Residues": 9, "Acidic Residues": 1, "Hydrophobic Residues": 5, "Polar Residues": 12, "Positive Residues": 9, "Negative Residues": 1, "SPADE ID": "SPADE_UN_25531", "Similar Sequences": [{"SPADE_ID": "SPADE_N_02277", "Similarity": 1.0, "Sequence": "GDFFRKSKEKIGKEFKRIVQRIKDFLRN"}, {"SPADE_ID": "SPADE_N_03132", "Similarity": 1.0, "Sequence": "FKRIVQRIKDFLR"}, {"SPADE_ID": "SPADE_N_04248", "Similarity": 1.0, "Sequence": "LLGDFFRKSKEKIGKEFKRIVQRIKDFLRN"}], "Hemolytic Activity": "", "Target Organism": "Staphylococcus aureus SH1000(MIC=>200µg/ml),Staphylococcus aureus MR(MIC=>200µg/ml),Pseudomonas aeruginosa PAO1(MIC=>200µg/ml)"}}}